Healthcare providers using Automated Impella Controllers need to understand four critical points from the FDA’s recent safety alert: the software error triggers unexpected device restarts; all controllers are potentially affected; hospitals must immediately review and strengthen their emergency response protocols; and the manufacturer is developing a corrective fix.
For clinical teams, this alert requires immediate action. Review existing emergency procedures specific to controller malfunctions and ensure all staff members—particularly those in intensive care settings—understand escalation pathways and alternative support options. Hemodynamic monitoring should be heightened for all patients currently supported by these devices, with attention to subtle signs of support interruption.
Documentation is equally important. Report any suspected controller restart incidents through the FDA’s Medical Device Reporting system to contribute to the safety database and help inform the manufacturer’s corrective actions. Stay informed as Abiomed releases updates on the fix timeline and deployment procedures.
Read the full article on GMJ Newsroom.
Was this article helpful?
